Patient P-01513
Synthetic patientNBL-101 · Day 90 · 65–74 · M · baseline S19Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Declining
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S19
- Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 14 GI-04 recommended — GI Support Protocol GI-04
- Day 15 Patient accepted — Started GI-04 in the companion
- Day 23 No meaningful change — GI Support Protocol GI-04
What changed?
Trajectory began diverging from predicted response on Day 10.
Primary contributors, last 14 days
- Inflammatory activity-11
- GI instability-8
- Nutritional resilience-5
- Toxicity+4
What helped?
- GI Support Protocol GI-04Day 14Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion15.3/100
improving · -2.2 vs previous 14 d
Toxicity
Blood13.6/100
improving · -3.5 vs previous 14 d
Sleep quality
Wearable54.5/100
stable · +0.2 vs previous 14 d
Energy level
Daily log6.8/10
stable · +0.2 vs previous 14 d
Stress level
Daily log3.2/10
improving · -0.2 vs previous 14 d
Steps
Wearable6,213
improving · +789 vs previous 14 d
Adherence
Companion90.5 %
stable · -1.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 78 from the failing basin, 26 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- GI-04 GI Support Protocolalready tried, no meaningful change
- Keep simple carbs lowGI +7 next day on high-intake days · n 18
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates+7detractor · 95%
- Histamine load-2.5no signal · 36%
- Dietary fat load+2.2no signal · 37%
- Spicy / capsaicin-1.5no signal · 21%
- Insoluble fibre-0.9no signal · 15%
- Alcohol+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- DPYD *2A heterozygousSlower drug clearance
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.5 · butyrate capacity 47/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 70 ms
- Sleep
- 6.9 h
- Steps
- 6,517
- Resting HR
- 68 bpm
Daily log: GI score 15, nutritional resilience 59, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01377 | 36% | S11 | AD-05 | no change | 42 |
| P-01541 | 36% | S09 | AD-05 | no change | 43 |
| P-01483 | 35% | S14 | AD-05 | no change | 35 |
| P-01679 | 33% | S12 | AD-05 | no change | 39 |
| P-01773 | 28% | S05 | AD-05 | improved | 27 |
| P-01804 | 28% | S19 | AD-05 | improved | 61 |
| P-01848 | 28% | S05 | AD-05 | no change | 23 |
| P-01468 | 35% | S06 | BR-03 | no change | 41 |
| P-01313 | 33% | S01 | BR-03 | improved | 32 |
| P-01450 | 33% | S09 | BR-03 | no change | 36 |
| P-01689 | 33% | S13 | BR-03 | no change | 50 |
| P-01350 | 32% | S19 | BR-03 | no change | 34 |